Compounds > azacitidine

azacitidine and Virus Diseases

azacitidine has been researched along with Virus Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Kedarinath, K; Parks, GD; Shiffer, EM1
Abboud, CN; Ali, AM; Cashen, AF; DiPersio, JF; Fehniger, TA; Gao, F; Ghobadi, A; Jacoby, MA; Oh, ST; Pusic, I; Romee, R; Schroeder, MA; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Wartman, LD; Weisel, D; Welch, JS; Westervelt, P1
Akria, L; Arad, A; Aviv, A; Braester, A; Dally, N; Filanovsky, K; Gafter-Gvili, A; Gatt, ME; Hellmann, I; Herishanu, Y; Herzog-Tzarfati, K; Leiba, R; Merkel, D; Mittelman, M; Nagler, A; Nemets, A; Ofran, Y; Ronson, A; Rouvio, O; Silbershatz, I; Tadmor, T; Vidal, L; Yeganeh, S1
Costa, S; Javier, KP; Linares, M; Orero, M; Ortiz, S; Pérez, PL; Roig, M; Villegas, C1
Bainschab, A; Greinix, HT; Krause, R; Quehenberger, F; Sill, H; Wölfler, A; Zebisch, A1
Cihák, A; Rada, B1

Other Studies

6 other study(ies) available for azacitidine and Virus Diseases

ArticleYear
DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus.
    Anti-cancer drugs, 2023, 09-01, Volume: 34, Issue:8

    Topics: Apoptosis; Azacitidine; Caspases; Cell Line, Tumor; Enzyme Inhibitors; Humans; Methyltransferases; Neuroblastoma; Virus Diseases

2023
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.
    Cancer medicine, 2017, Volume: 6, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Missouri; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Virus Diseases

2017
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:6

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Bacterial Infections; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Myelodysplastic Syndromes; Platelet Count; Risk Factors; Virus Diseases

2015
Infection Rate and Risk Factors in Patients Treated With Azacitidine.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:9

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Bacterial Infections; Female; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Virus Diseases

2015
Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis.
    Leukemia research, 2016, Volume: 42

    Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antimetabolites, Antineoplastic; Azacitidine; Bacterial Infections; Cytarabine; Decitabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Virus Diseases

2016
Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review).
    Neoplasma, 1976, Volume: 23, Issue:3

    Topics: Animals; Azacitidine; Azauridine; Molecular Weight; Neoplasms, Experimental; Phosphotransferases; Pyrimidine Nucleosides; Pyrimidines; Species Specificity; Uridine; Uridine Kinase; Virus Diseases

1976